GSK, Glenmark Resolve Malaria Drug Patent Dustup

Law360, New York (April 12, 2010, 3:07 PM EDT) -- GlaxoSmithKline LLC and Glenmark Generics Ltd. have settled GSK's patent infringement suit over the India-based generic-drug maker's bid to introduce its own version of anti-malaria drug Malarone in the U.S., the companies announced Monday.

A stipulation and order filed Monday in the U.S. District Court for the District of Delaware, where the case is pending, said the action was stayed for 60 days to permit review of the settlement by government authorities, including the Federal Trade Commission and the U.S. Department of Justice.

Glenmark's U.S.-based subsidiary...
To view the full article, register now.